Cargando…

Mutant allelic burden in acute myeloid leukaemia: Why bother?

Detalles Bibliográficos
Autores principales:	Touw, Ivo P., Sanders, Mathijs A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154759/ https://www.ncbi.nlm.nih.gov/pubmed/31580476 http://dx.doi.org/10.1111/bjh.16240

Ejemplares similares

Single-Trial Analyses: Why Bother?
por: Pernet, Cyril R., et al.
Publicado: (2011)

Applying the science of measurement to biology: Why bother?
por: Coxon, Carmen H., et al.
Publicado: (2019)

Growing plants in fluctuating environments: why bother?
por: Matsubara, Shizue
Publicado: (2018)

Critical incident reporting: Why should we bother?
por: Tewari, Anurag, et al.
Publicado: (2013)

Why bother with a COST Action? The benefits of networking in science
por: Kostelidou, Kalliopi, et al.
Publicado: (2010)

Epigenetic Gene Mutations Impact on Outcome in Acute Myeloid Leukaemia
por: Young, Christine S., et al.
Publicado: (2015)

Allelic Imbalance of Recurrently Mutated Genes in Acute Myeloid Leukaemia
por: Batcha, Aarif M. N., et al.
Publicado: (2019)

Why bother: usefulness and effect of young surgeon committees in surgical societies
por: Lutz, Brigitta M., et al.
Publicado: (2018)

The emergence of antihistamines as unexpected allies in our fight against acute myeloid leukaemia
por: Winter, Stuart S.
Publicado: (2019)

Why Bother About Clumsiness? The Implications of Having Developmental Coordination Disorder (DCD)
por: Gillberg, Christopher, et al.
Publicado: (2003)

Quality management systems for your in vitro fertilization clinic's laboratory: Why bother?
por: Olofsson, Jan I, et al.
Publicado: (2013)

Providing a molecular mechanism for P-glycoprotein; why would I bother?
por: Callaghan, Richard
Publicado: (2015)

Why bother the public? A critique of Leslie Cannold’s empirical research on ectogenesis
por: Smajdor, Anna
Publicado: (2021)

Preferential transcription of the mutated allele in NPM1 mutated acute myeloid leukaemia
por: Bailey, G. D., et al.
Publicado: (2020)

Why do we bother? Exploring biologists' motivations to share the details of their teaching practice
por: Scott, Graham
Publicado: (2015)

Why are patients with chronic myeloid leukaemia (non-)adherent?
por: Abraham, I, et al.
Publicado: (2012)

Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
por: Ladikou, E. E., et al.
Publicado: (2020)

The curious case of IDH mutant acute myeloid leukaemia: biochemistry and therapeutic approaches
por: Gruber, Emily, et al.
Publicado: (2023)

Hiccups that bother Big Bang machine
Publicado: (2009)

Treating second‐relapsed/refractory first‐relapsed childhood acute myeloid leukaemia: Successful salvage rather than palliation?
por: Merli, Pietro
Publicado: (2022)

TP53-mutant myelodysplastic syndrome and acute myeloid leukemia: the black hole of hematology
por: Patel, Shyam A., et al.
Publicado: (2022)

Vitamin C-induced epigenomic remodelling in IDH1 mutant acute myeloid leukaemia
por: Mingay, M, et al.
Publicado: (2018)

“It Bothered Me”: The Mental Burden of COVID-19 Media Reports on Community-Dwelling Elderly People
por: Maksimovic, Natasa, et al.
Publicado: (2023)

Alliance of galectin-3 and CD74 biochemical networks as a crucial component of survival machinery operated by human acute myeloid leukaemia cells
por: Yasinska, Inna M., et al.
Publicado: (2019)

Targeting apoptosis in acute myeloid leukaemia
por: Cassier, Philippe A, et al.
Publicado: (2017)

Role of apoptotic markers in paediatric acute lymphoblastic leukaemia
por: Kapoor, Gauri, et al.
Publicado: (2018)

Clinical relevance of mutant NPM1 and CEBPA in patients with acute myeloid leukaemia – preliminary report
por: Helbig, Grzegorz, et al.
Publicado: (2014)

Adhesion Deregulation in Acute Myeloid Leukaemia
por: Gruszka, Alicja M., et al.
Publicado: (2019)

Murine Models of Acute Myeloid Leukaemia
por: Almosailleakh, Marwa, et al.
Publicado: (2019)

Wnt Signalling in Acute Myeloid Leukaemia
por: Gruszka, Alicja M., et al.
Publicado: (2019)

Classification of pediatric acute myeloid leukemia based on miRNA expression profiles
por: Obulkasim, Askar, et al.
Publicado: (2017)

Does Bother/Distress Contribute to the Diagnosis of Premature Ejaculation?
por: Rowland, David L., et al.
Publicado: (2022)

Digging into the HLA pockets: A new association with acute leukaemias
por: Gurnari, Carmelo, et al.
Publicado: (2022)

IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia
por: Kuett, Alexander, et al.
Publicado: (2015)

Acute myeloid leukaemia relapse presenting as cardiac myeloid sarcoma
por: Waselewski, Alexander, et al.
Publicado: (2018)

Association of gene polymorphisms with development of cancer risk or their protective role associated with some mutant alleles
por: Nayeemuddin, Khazi M., et al.
Publicado: (2011)

Application of Bother in patient reported outcomes instruments across cultures
por: Gawlicki, Mary C, et al.
Publicado: (2014)

Wrist deformity, bother and function following wrist fracture in the elderly
por: Lawson, Andrew, et al.
Publicado: (2020)

Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
por: Merlevede, Jane, et al.
Publicado: (2016)

Intronless WNT10B-short variant underlies new recurrent allele-specific rearrangement in acute myeloid leukaemia
por: Lazzaroni, Francesca, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7134455rnvvkaq1t7rqjpomlsu